AU3212700A - Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer - Google Patents
Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancerInfo
- Publication number
- AU3212700A AU3212700A AU32127/00A AU3212700A AU3212700A AU 3212700 A AU3212700 A AU 3212700A AU 32127/00 A AU32127/00 A AU 32127/00A AU 3212700 A AU3212700 A AU 3212700A AU 3212700 A AU3212700 A AU 3212700A
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic
- prostate cancer
- acid phosphatase
- diagnostic applications
- prostatic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03002—Acid phosphatase (3.1.3.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11655199P | 1999-01-21 | 1999-01-21 | |
US60116551 | 1999-01-21 | ||
PCT/US2000/001599 WO2000043548A1 (en) | 1999-01-21 | 2000-01-21 | Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3212700A true AU3212700A (en) | 2000-08-07 |
Family
ID=22367878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU32127/00A Abandoned AU3212700A (en) | 1999-01-21 | 2000-01-21 | Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3212700A (en) |
WO (1) | WO2000043548A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20041453A0 (en) * | 2004-11-11 | 2004-11-11 | Pirkko Vihko | Knockout Animals |
WO2008112283A2 (en) * | 2007-03-12 | 2008-09-18 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment |
GB2484058A (en) * | 2009-12-01 | 2012-04-04 | Uni Konstanz | Prostate cancer DNA vaccine |
CN113711991A (en) * | 2020-11-02 | 2021-11-30 | 江门赛尔康生物科技有限公司 | Construction method and application of PAP (PAP) -targeted drug screening animal model |
CN113455465B (en) * | 2021-06-29 | 2023-02-28 | 安徽省立医院(中国科学技术大学附属第一医院) | Method for constructing nude mouse subcutaneous transplantation model of human prostate cancer LNCaP cell |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162504A (en) * | 1988-06-03 | 1992-11-10 | Cytogen Corporation | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
US5773215A (en) * | 1989-10-24 | 1998-06-30 | Board Of Regents, The University Of Texas System | Tumor marker protein for cancer risk assessment |
US5935818A (en) * | 1995-02-24 | 1999-08-10 | Sloan-Kettering Institute For Cancer Research | Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof |
US5882864A (en) * | 1995-07-31 | 1999-03-16 | Urocor Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
US5763415A (en) * | 1995-08-03 | 1998-06-09 | John Hopkins University School Of Medicine | Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
-
2000
- 2000-01-21 AU AU32127/00A patent/AU3212700A/en not_active Abandoned
- 2000-01-21 WO PCT/US2000/001599 patent/WO2000043548A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000043548A1 (en) | 2000-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7994200A (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
IL140845A0 (en) | Compositions for therapy and diagnosis of prostate cancer | |
HUP0203968A3 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
AU2003302892A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AUPQ923100A0 (en) | Treatment of prostate cancer | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU6502199A (en) | Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
IL136167A0 (en) | Conjugates useful in the treatment of prostate cancer | |
AUPQ201499A0 (en) | Treatment of inflammatory and malignant diseases | |
AU3212700A (en) | Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU5638400A (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2238499A (en) | Androgen-metabolic gene mutations and prostate cancer risk | |
AU2193797A (en) | Delivery of therapeutic agents to the prostate | |
AU1490801A (en) | Targeted delivery of therapeutic and diagnostic moieties | |
AU6111800A (en) | 26 human prostate and prostate cancer associated proteins | |
AU4452900A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2001271284A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
ZA9810974B (en) | Conjugates useful in the treatment of prostate cancer | |
AU2001296224A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |